NAS:BMRN (USA) Also trade in: Austria Germany UK

Biomarin Pharmaceutical Inc

$ 82.47 0.1 (0.12%)
On watch
Volume: 700,830 Avg Vol (1m): 1,388,916
Market Cap $: 14.77 Bil Enterprise Value $: 14.71 Bil
P/E (TTM): 0.00 P/B: 5.03
Earnings Power Value -12.37
Net Current Asset Value 2.35
Tangible Book 12.64
Projected FCF -7.72
Median P/S Value 99.99
Graham Number 0
Peter Lynch Value 0
DCF (FCF Based) 0
DCF (Earnings Based) 0
1Y (-%)

BMRN Stock Institutional Ownership and Insider Ownership - Biomarin Pharmaceutical

Shares Outstanding
260.38 (Mil)
Institutional Ownership
1.62 (Mil)
Insider Ownership
159.36 (Mil)
Float Percentage of TSO

Short Interest History (%)

Due to a license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus’ website, except for certain Australian stocks.

Institutional Ownership History (%)

This the Institutional Ownership History of Biomarin Pharmaceutical Inc. Peter Lynch prefers to buy companies with low institutional ownership.

Insider ownership (%)

This is the historical insider ownership of Biomarin Pharmaceutical Inc. It is usually better to buy companies with large insider ownership. The company insiders' interest are more aligned with external shareholders in this case.

Top Direct Holders

Top Fund Holders